Sudarshan Pharma Industries Limited (BOM:543828)

BOM:543828 Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	11.35	5.51	1.44	117.19	2.36
Short-Term Investments	-	15	15	-	-
Cash & Short-Term Investments	11.35	20.51	16.44	117.19	2.36
Cash Growth	-44.66%	24.76%	-85.97%	4865.47%	-81.19%
Accounts Receivable	2,333	1,602	1,225	815.09	734.77
Other Receivables	-	9.42	77.16	6.1	2.69
Receivables	2,333	1,657	1,303	929.89	737.46
Inventory	2,187	1,405	857.41	745.68	468.7
Prepaid Expenses	-	20.31	17.84	4.76	1.82
Other Current Assets	370.5	245.71	177.89	188.71	85.46
Total Current Assets	4,903	3,348	2,372	1,986	1,296
Property, Plant & Equipment	808.48	260.91	224.1	190.03	68.84
Long-Term Investments	0.02	288.4	123.41	123.41	0.02
Goodwill	52.2	34.88	43.59	-	-
Other Intangible Assets	99.68	3.31	6.15	8.97	1.19
Other Long-Term Assets	554.47	77.32	51.18	5.85	0.49
Total Assets	6,417	4,024	2,831	2,325	1,375

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	1,877	918.33	567.15	918.89	737.51
Accrued Expenses	0.19	8.66	44.29	29.1	24.25
Short-Term Debt	-	1,566	905.59	183.52	235.92
Current Portion of Long-Term Debt	2,551	36.85	37.87	29.63	20.6
Current Portion of Leases	13.08	-	-	-	-
Current Income Taxes Payable	71.63	51.75	24.36	6.4	3.26
Other Current Liabilities	48.04	15.49	25.65	17.22	4.7
Total Current Liabilities	4,561	2,597	1,605	1,185	1,026
Long-Term Debt	283.69	104.6	104.91	127.88	49.4
Long-Term Leases	2.59	-	-	-	-
Pension & Post-Retirement Benefits	-	1.34	0.7	0.5	0.31
Long-Term Deferred Tax Liabilities	1.51	2.86	0.18	1.8	1.41
Other Long-Term Liabilities	5.34	3.54	3.48	0.09	0.11
Total Liabilities	4,854	2,709	1,714	1,315	1,077

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	240.66	240.66	240.66	240.66	97.49
Additional Paid-In Capital	-	578.08	578.1	578.1	79.66
Retained Earnings	-	457.86	298.31	190.97	120.61
Comprehensive Income & Other	1,310	38.21	-	-	-
Total Common Equity	1,551	1,315	1,117	1,010	297.75
Minority Interest	12.21	0.01	-	-	-
Shareholders' Equity	1,563	1,315	1,117	1,010	297.75
Total Liabilities & Equity	6,417	4,024	2,831	2,325	1,375

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	2,850	1,707	1,048	341.04	305.92
Net Cash (Debt)	-2,839	-1,687	-1,032	-223.85	-303.56
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-11.82	-6.98	-4.32	-0.93	-2.11
Filing Date Shares Outstanding	223.46	240.66	240.66	240.66	166.78
Total Common Shares Outstanding	223.46	240.66	240.66	240.66	146.23
Working Capital	341.46	751.53	767.29	801.45	269.55
Book Value Per Share	6.94	5.46	4.64	4.20	2.04
Tangible Book Value	1,399	1,277	1,067	1,001	296.56
Tangible Book Value Per Share	6.26	5.30	4.44	4.16	2.03
Land	-	104.73	104.73	104.73	3.21
Buildings	-	15.3	15.3	14.77	14.77
Machinery	-	122.53	116.67	92.14	62.9
Construction In Progress	-	60.41	18.8	0.12	5.36

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 23, 2026

Data Sources Report a data error